Recommended Tools
AbSeek™ encompasses antibody sequence analysis, structure and function prediction, lead optimization, de novo generation, and visualization, among others, covering all stages of antibody discovery and engineering from screening to optimization for efficient innovation.
Free Tools Limited Time
Sequence Analysis
Function Prediction
Lead Optimization
Structure Prediction
New
Molecule Generation

Features & Advantages
Integration
Combines multiple algorithms to provide a one-stop service that meets all needs in antibody discovery and engineering.
Expertise
Tailors UI and data visualization methods based on the characteristics of antibody data for better suitability.
Advancement
Continuously updates cutting-edge AI algorithms to ensure the platform's timeliness and advancement.
Data Security
Committed to providing users with a secure and reliable data environment, alleviating concerns about data leakage.
News
Cyagen Talk|AI-Powered Antibody Discovery: From HUGO-Ab Mice to Predictive Models
AbSeek™: Intelligent Antibody Computational Platform
2025-03-19
More >>【Frontier Express】Cancer Discovery | HER2 Heterogeneity Reveals New Mechanisms of Drug Resistance and Therapeutic Strategies in Breast Cancer
2026-08-05
【Frontier Express】Signal Transduction and Targeted Therapy | BCL9 inhibition promotes fibroblast lipogenesis by regulating macrophage–fibroblast interactions to attenuate pulmonary fibrosis
2026-08-05
【Frontier Express】Nature Communications | TFR1 Binding to the VP1u Domain of Human Parvovirus B19 Promotes Viral Entry
2026-08-04
【Frontier Express】Nature Communications | Endothelial cell-secreted SPARC suppresses astrocytic CD59 expression by inhibiting VEGFA/VEGFR2 signaling and promotes astrocytopathy in a mouse model of neuromyelitis optica spectrum disorders
2026-08-04
【Frontier Express】Nature Communications | A Randomized Phase II Trial of Carboplatin with or without Nivolumab in Metastatic Triple-Negative Breast Cancer
2026-08-03
【Frontier Express】Nature Communications | Efficacy and Safety of Cadonilimab Plus Chemotherapy as First-Line Treatment for PD-L1-Negative Advanced Non-Small Cell Lung Cancer
2026-08-03
【Frontier Express】Nature Communications | Tumor stromal microenvironment regulates lung cancer response to targeted therapy through multifactorial sheltering mechanisms
2026-08-03






